A Mayo Clinic study suggests postmenopausal women lost 35% more weight combining hormone therapy with tirzepatide, though ...

A Mayo Clinic study found that postmenopausal women using menopausal hormone therapy lost about 35% more weight on tirzepatide than women taking tirzepatide alone. The result suggests a possible ...

Feb. 5, 2026 -- In 2025, the U.S. FDA removed the “black box” warnings from menopausal hormone therapy products – but what does that actually mean for patients? For decades, many women have navigated ...

You may have heard about hormone-balancing diets and certain dishes to tweak hormone levels. But is there such a thing as a ...

The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal ...

If you’ve ever had a hunch your hormones were off, that might be because you’ve been hearing about it everywhere. From low-cortisol workouts to cycle syncing, it seems like there are hormone-balancing ...

The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task ...